Immunogen reported $9.73M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.07B 228M
Acceleron Pharma XLRN:US $ 35.47M 4.41M
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Amgen AMGN:US $ 1.38B 130M
Arena Pharmaceuticals ARNA:US $ 31.94M 2.48M
Astellas Pharma 4503:JP 137.11B 4.16B
AstraZeneca AZN:LN 2.57B 76M
Bluebird Bio BLUE:US $ 78.58M 8.3M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Cerulean Pharma CERU:US $ 1.82M 142.69K
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Eli Lilly And LLY:US $ 1.69B 109.7M
Emergent Biosolutions EBS:US $ 91.2M 10.3M
Exelixis EXEL:US $ 98.49M 3.86M
Halozyme Therapeutics HALO:US $ 12.32M 1.26M
Heron Therapeutics HRTX:US $ 33.16M 8.35M
Immunogen IMGN:US $ 9.73M 481K
Intrexon XON:US $ 20M 1.3M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Macrogenics MGNX:US $ 15.23M 198K
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Novartis NVS:US 3.71B 190M
Pfizer PFE:US $ 2.79B 134M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Seattle Genetics SGEN:US $ 165.13M 5.29M